retatrutide mechanism retatrutide clinical trials 2024 2025 trial results press release A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity Lilly's triple agonist, retatrutide, delivered – Retatrutide for the treatment of

US$ 23.56

★★★★★ 4.5 (13 reviews)

US$ 29.60

★★★★★ 4.4 (26 reviews)

US$ 21.43

★★★★★ 4.1 (22 reviews)

US$ 24.76

★★★★★ 4.9 (27 reviews)

US$ 20.41

★★★★★ 4.6 (20 reviews)

US$ 25.75

★★★★★ 4.2 (27 reviews)

US$ 26.42

★★★★★ 5.0 (25 reviews)

US$ 29.19

★★★★★ 4.2 (22 reviews)

US$ 25.34

★★★★★ 4.9 (24 reviews)

US$ 27.96

★★★★★ 4.7 (27 reviews)

US$ 28.46

★★★★★ 4.2 (23 reviews)

US$ 25.26

★★★★★ 4.5 (16 reviews)

US$ 22.25

★★★★★ 5.0 (12 reviews)

US$ 28.21

★★★★★ 4.6 (8 reviews)

US$ 27.79

★★★★★ 4.5 (29 reviews)

US$ 27.33

★★★★★ 4.8 (12 reviews)

US$ 28.71

★★★★★ 4.8 (27 reviews)

US$ 29.94

★★★★★ 4.0 (16 reviews)

US$ 23.36

★★★★★ 4.1 (26 reviews)

US$ 20.85

★★★★★ 4.8 (20 reviews)